Back to search results

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Abroad (travel likely)RecruitingPHASE1

Conditions

Living Donor Kidney Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Stanford University, Palo Alto, California, United States

    Contact: Study coordinator (Renata Gilfanova) · Rgilfan@stanford.edu · 650-736-0245
    Contact: Study coordinator (Stephan Busque, MD) · sbusque@stanford.edu · 650-498-6189
    Contact: Principal Investigator (Everett Meyer, MD)
    Robert Lowsky, MD (Sub-investigator)
    Richard Hoppe, MD (Sub-investigator)
    John Scandling, MD (Sub-investigator)
    Kent Jensen, PhD (Sub-investigator)
    Contact: Principal Investigator (Stephan Busque, MD)
    Colin Lenihan, MD (Sub-investigator)
    Thomas Pham, MD (Sub-investigator)

  • Nothwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Leah Goudy, RN) · leah.goudy@northwestern.edu · 312-694-0242
    Contact: Study coordinator (Joseph Leventhal, MD) · jleventh@nm.org · 312-695-8900
    Jayesh Mehta, MD (Sub-investigator)
    James Mathew, PhD (Sub-investigator)
    Lorenzo Gallon, MD (Sub-investigator)
    Contact: Principal Investigator (Joseph Leventhal, MD)
Study leads

  • Everett Meyer, MD

    Study Director

    Stanford University

View source on ClinicalTrials.gov(opens in a new tab)